Royal Caribbean Cruises sell BiotechBee
Start price
21.09.22
/
70%
€47.73
Target price
31.12.24
€39.00
Performance (%)
-2.79%
End price
02.01.23
€46.40
Summary
This prediction ended on 02.01.23 with a price of €46.40. With a performance of -2.79%, the SELL prediction for Royal Caribbean Cruises by BiotechBee was down slightly. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Royal Caribbean Cruises | -8.268% | -8.268% | 6.134% | 309.029% |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% | 63.911% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% | 108.934% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% | 57.329% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% | 67.940% |
According to BiotechBee what are the pros and cons of Royal Caribbean Cruises for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Royal Caribbean Cruises diskutieren
Sell mit Kursziel 39,0